Quick Answer
GILEAD SCIENCES, INC. reported R&D Expense of $9.11 billion for fiscal year 2019.
GILEAD SCIENCES, INC. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2019 | $9.11B | +81.5% |
| 2018 | $5.02B | +34.4% |
| 2017 | $3.73B | -26.8% |
| 2016 | $5.10B | +69.1% |
| 2015 | $3.01B | +5.6% |
| 2014 | $2.85B | +34.6% |
| 2013 | $2.12B | +20.5% |
| 2012 | $1.76B | +43.2% |
| 2011 | $1.23B | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| March 31, 2020 | $1.10B | +4.2% | -77.9% |
| September 30, 2019 | $4.99B | +431.4% | +330.2% |
| June 30, 2019 | $1.16B | -2.7% | +9.7% |
| March 31, 2019 | $1.06B | +12.8% | +12.6% |
| September 30, 2018 | $939.00M | +19.0% | -21.2% |
| June 30, 2018 | $1.19B | +38.0% | +27.2% |
| March 31, 2018 | $937.00M | +0.6% | +18.8% |
| September 30, 2017 | $789.00M | -30.9% | -8.7% |
- GILEAD SCIENCES, INC. showed an increase of +81.5% in R&D Expense compared to the prior fiscal year.
- Over the 2011–2019 period, GILEAD SCIENCES, INC.’s r&d expense has grown by 640.8% (from $1.23 billion to $9.11 billion).
- The most recent figure is from GILEAD SCIENCES, INC.’s fiscal year 2019 report (Form 10-K), filed with the SEC on February 25, 2020.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: